Frontiers in Drug, Chemistry and Clinical Research最新文献

筛选
英文 中文
Boosting effect of pre-existing immunity on anti-cancer immunotherapies 预先免疫在抗癌免疫治疗中的增强作用
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/fdccr.1000155
M. Conti
{"title":"Boosting effect of pre-existing immunity on anti-cancer immunotherapies","authors":"M. Conti","doi":"10.15761/fdccr.1000155","DOIUrl":"https://doi.org/10.15761/fdccr.1000155","url":null,"abstract":"neo-Abstract Intratumoral application of intact microbes and/or foreing antigens is a promising strategy in anti-cancer immunotherapy since, after the induced immune activation, antigen spread toward tumor-associated antigens and/or neo-antigens can generate an anti-tumor vaccine effect. However, the strong immunosuppressive nature of the tumor microenvironment (TME) has been shown most often to curb the mounting of an effective immune response. By examining the literature, we found evidence that pre-existing immunity to foreign antigens has a crucial role in determining the actual degree of immune activation obtainable. Therefore, assessing or even voluntarily inducing pre-existing immunity to specific foreign antigens can help develop successful immunotherapy. Furthermore, pre-existing immunity to common pathogens developed by previous infection and/or vaccination could be exploited to turn cold tumors into hot ones, a most desired condition for successful checkpoint inhibitor based anti-cancer immunotherapy.","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"79 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124596416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Alkaline phosphatases, B6 vitamers and Pre-eclampsia 碱性磷酸酶,维生素B6和先兆子痫
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/fdccr.1000122
Medina Ja, D. Rabelo, R. C. B. Alves, D. Maria
{"title":"Alkaline phosphatases, B6 vitamers and Pre-eclampsia","authors":"Medina Ja, D. Rabelo, R. C. B. Alves, D. Maria","doi":"10.15761/fdccr.1000122","DOIUrl":"https://doi.org/10.15761/fdccr.1000122","url":null,"abstract":"","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"124 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117326489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which is the best strategy for using diuretics in decompensated chronic heart failure? 在失代偿性慢性心力衰竭中使用利尿剂的最佳策略是什么?
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/fdccr.1000127
B. Vincenzo, D. Martina, De Marco
{"title":"Which is the best strategy for using diuretics in decompensated chronic heart failure?","authors":"B. Vincenzo, D. Martina, De Marco","doi":"10.15761/fdccr.1000127","DOIUrl":"https://doi.org/10.15761/fdccr.1000127","url":null,"abstract":"Heart failure is a common clinical syndrome with symptoms and signs caused by cardiac dysfunction with inability of the heart to supply the metabolic demands of peripheral tissues with the required amount of blood and oxygen. HF is a chronic condition that may worsen acutely. This condition, known as decompensated heart failure, presents with symptoms and signs related to congestion. Although diuretics are drugs of first choice to control fluid retention, diuretic therapy is still empirical and no conclusive data are available on how these drugs should be managed in decompensated heart failure. Here, we review the role of the different diuretics in decompensated heart failure and we illustrate the different strategies of diuretic therapy that have been proposed in literature. decompensated Mineralocorticoid receptor antagonists.","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126184445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and anti-Trypanosoma cruzi profile of the novel 4-thiazolidinone and 1,3-thiazole derivatives 新型4-噻唑烷酮和1,3-噻唑衍生物的合成及抗克氏锥虫谱分析
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/FDCCR.1000120
de Siqueira Lrp, M deOliveiraBarbosa, Oliveira Ar, de Moraes Gomes Pat, de Oliveira Filho Gb, Demcheva Mv, Hernandes Vp, D. Ac, J. Pas, Romanha Aj, Leite Acl
{"title":"Synthesis and anti-Trypanosoma cruzi profile of the novel 4-thiazolidinone and 1,3-thiazole derivatives","authors":"de Siqueira Lrp, M deOliveiraBarbosa, Oliveira Ar, de Moraes Gomes Pat, de Oliveira Filho Gb, Demcheva Mv, Hernandes Vp, D. Ac, J. Pas, Romanha Aj, Leite Acl","doi":"10.15761/FDCCR.1000120","DOIUrl":"https://doi.org/10.15761/FDCCR.1000120","url":null,"abstract":"Chagas disease is a serious public health problem in Brazil and world. Caused by the protozoan Trypanosoma cruzi, it is estimated 6-7 million people infected worldwide. The only drug used to treatment is Benzonidazole, but this drug is only effective in the acute phase of the disease. This paper reports the synthesis and the anti-Trypanosoma cruzi activity of 4-thiazolidinone and 1,3-thiazole derivatives based in thiosemicarbazones previously described as potent trypanocidal agent, planned through the bioisosterism strategy. Therefore, the synthesis of 28 aryl-4-thiazolidinones (2a-r and 3a-j) was achieved, which aryl ring possesses halogens atoms in meta and para positions, and the heterocyclic system had lipophilic substituents. These compounds were thus evaluated as anti-T. cruzi agents against epimastigote, trypomastigote and amastigote forms of T. cruzi. Compounds were also tested its toxicity in L929 fibroblasts. In view to investigate a bioisosteric relationship between 1,3-thiazoles and 4-thiazolidinones, eighteen 1,3thiazoles derived from trifluoromethyl thiosemicarbazone (4a-r) were also tested in the same model. It was possible to show that between the 46 tested compounds, those that possess a bromine (2a-r) atom showed better activity compared to compounds substituted by a trifluoromethyl group (3a-j) and to 1,3-thiazole derivatives (4a-r), which were inactive. In general, the 2a-r series showed low toxic profile in the cell line tested. Besides, compound 2h was the most active of then all when compared to the standard Benznidazole. *Correspondence to: Ana Cristina Lima Leite, Laboratório de Planejamento em Química Medicinal, Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Pernambuco, 50740-520, Recife, PE, Brazil, E-mail: acllb2003@yahoo.com.br","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134019512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Colorectal carcinogenesis, colorectal cancer development and Fusobacterium nucleatum 结直肠癌发生、结直肠癌发展与核梭杆菌
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/fdccr.1000152
T. Ohara
{"title":"Colorectal carcinogenesis, colorectal cancer development and Fusobacterium nucleatum","authors":"T. Ohara","doi":"10.15761/fdccr.1000152","DOIUrl":"https://doi.org/10.15761/fdccr.1000152","url":null,"abstract":"Many studies of colorectal cancer and gut microbiota have been reported since Fusobacterium nucleatum (F. nucleatum) was reported to be involved in carcinogenesis and cancer development. The reports range from inflammation to carcinogenesis / development, avoidance from the immune system, effects on oncogenes / tumor suppressor genes, cell growth promotion, and tumor cell adhesion. There is a report suggesting that F. nucleatum is involved in the development of cancer, which is a poor prognosis due to large amounts of bacteria as the stage progression. In addition, F. nucleatum has been reported to be associated with CIMP-high, microsatellite instability and MLH1 hypermethylation. This is a report suggesting that F. nucleatum may be involved not only in the carcinogenic pathway from adenomas but also in the carcinogenic pathway from serrated adenomas. In addition, F. nucleatum is an indigenous bacterium in the oral cavity and is also a causative bacterium of periodontal disease, but there is a report that the strains of colorectal cancer and F. nucleatum in the oral cavity are the same, and its carcinogenic mechanism is drawing attention. In this review, I will outline the relationship between colorectal carcinogenesis and colorectal cancer development and F. nucleatum, and also address the issues. *Correspondence to: Tadashi Ohara, M.D, Ph.D, Department of Gastroenterology, Kitashinagawa Third Hospital, Kohno Clinical Medicine Research Institute, 3-37 Kitashinagawa, Shinagawa, Tokyo 140-0001, Japan, Tel: +81-3-34741831; Fax: +81-5461-3740; E-mail: t.ohara@kcmi.or.jp Received: May 02, 2021; Accepted: May 12, 2021; Published: May 17, 202","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"329 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134428422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Flavonoid chemistry and neuroprotection 类黄酮化学与神经保护
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/fdccr.1000140
Douglas Vieira Thomaz
{"title":"Flavonoid chemistry and neuroprotection","authors":"Douglas Vieira Thomaz","doi":"10.15761/fdccr.1000140","DOIUrl":"https://doi.org/10.15761/fdccr.1000140","url":null,"abstract":"This short commentary is intended to highlight the relevance of flavonoids in the therapeutics against neurodegenerative disorders. In this sense, this work briefly discuss the physicochemical and biological aspects which may be involved in the biological effects of these phytocomponents against oxidative stress in brain cells. Considering that literature abundantly describes the relevance of flavonoids in neuroprotection, care must be taken regarding their true clinical effectiveness, given the lack of information regarding their pharmacokinetic profiles and adequate pharmaceutical formulation.","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131696866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Does pomegranate protect against gamma-rays-induced cardiac illnesses in rats? 石榴能防止大鼠患γ射线引起的心脏病吗?
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/FDCCR.1000147
S. Tawfik, A. El-Kady, Heba H. Mansour
{"title":"Does pomegranate protect against gamma-rays-induced cardiac illnesses in rats?","authors":"S. Tawfik, A. El-Kady, Heba H. Mansour","doi":"10.15761/FDCCR.1000147","DOIUrl":"https://doi.org/10.15761/FDCCR.1000147","url":null,"abstract":"Pomegranate is a heart healthy fruit juice. The study aims to evaluate the effectiveness of pomegranate powder extract (Pom) in preventing γ -rays-induced cardiac illnesses in rat model. Rats were randomly divided into four groups of 10. Control group received 0.2ml diluted ethanol (vehicle) for 20days; Irradiated (IR) group received the vehicle for 10days, exposed to 8Gy- γ -rays and then given the vehicle for additional 10days; Pom group received 50mg Pom/kg body weight for 20days, and Pom+IR group received Pom for 10days then, rats were exposed to 8Gy- γ -rays and received Pom for additional 10days. Irradiated rats showed increased lipid peroxidation (LPO) and total nitrate/nitrite (NO(x)), and decreased levels of reduced glutathione (GSH) content, and the relative antioxidant enzyme activity of superoxide dismutase (SOD), glutathione peroxidase (GSHPx) and total antioxidant capacity (TAC) in the heart homogenates. Besides, asymmetric dimethylarginines (ADMA) was augmented in serum. Myocardial necrosis, edema, and inflammation were evident through the light microscope examination. Pre-treated rats with Pom significantly prevented or resisted all these alterations. Oral pre-treatment with Pom was effective in cardio protection in the γ -irradiated rats.","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115167005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Alternative therapeutic strategies to fight bacterial infections 对抗细菌感染的替代治疗策略
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/FDCCR.1000115
Leila Mousavifar, R. Roy
{"title":"Alternative therapeutic strategies to fight bacterial infections","authors":"Leila Mousavifar, R. Roy","doi":"10.15761/FDCCR.1000115","DOIUrl":"https://doi.org/10.15761/FDCCR.1000115","url":null,"abstract":"In spite of the large arsenal of antibiotherapies that have help humanities fighting bacterial infections, we are still facing diseases, hospitalization, and death caused by pathogenic agents [1-8]. The advent of the first sulfa drugs in the mid-thirties has launched almost a century of race toward the discoveries of new therapeutic agents by the pharmaceutical industries. The development of the Gram +ve linezolid in 2000 as the first family members of oxazolidinones as well as the Gram-negative lipopeptide antibiotic daptomycin, first discovered by Eli Lilly in 1980 but commercialized in the US in 2003 (23 years gap) have successfully lifted the long innovation gap in the medicinal chemistry era (Figure 1). Ceftaroline, a member of the fifth-generation cephalosporins discovered in 2010 is known to be particularly active against methicillin resistant Staphylococcus aureus (SARM), thus marking the beginning of alternative weapons against this particularly resilient infectious agent.","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116185274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Tailoring Specialized Scoring Functions For More Efficient Virtual Screening 定制专门的评分功能,更有效的虚拟筛选
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/FDCCR.1000118
Tatiana F. Vieira, Rita P. Magalhães, S. Sousa
{"title":"Tailoring Specialized Scoring Functions For More Efficient Virtual Screening","authors":"Tatiana F. Vieira, Rita P. Magalhães, S. Sousa","doi":"10.15761/FDCCR.1000118","DOIUrl":"https://doi.org/10.15761/FDCCR.1000118","url":null,"abstract":"","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130183924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Exploration of the protein targets and function mechanism of tricetin based on surface plasmon resonance and reverse molecular docking 基于表面等离激元共振和反向分子对接的三曲霉素蛋白靶点及作用机制探索
Frontiers in Drug, Chemistry and Clinical Research Pub Date : 1900-01-01 DOI: 10.15761/fdccr.1000126
Yuan Y, Wang N, Zhu F, Shen M, Chen K
{"title":"Exploration of the protein targets and function mechanism of tricetin based on surface plasmon resonance and reverse molecular docking","authors":"Yuan Y, Wang N, Zhu F, Shen M, Chen K","doi":"10.15761/fdccr.1000126","DOIUrl":"https://doi.org/10.15761/fdccr.1000126","url":null,"abstract":"Tricetin is a type of flavonoid that plays an important role in anti-cancer activity. However, the protein targets and function mechanism of tricetin in HepG2 cells remain unclear, which greatly limits its clinical application. In this paper, tricetin was immobilized by 3D photo cross linking chip and the microfluidic environment was established. The SPR (surface plasmon resonance) technique was used to monitor the protein targets interacting with the tricetin on the surface of the chip. The target proteins captured by tricetin in HepG2 cell were identified by HPLC-MS (high performance liquid chromatography-mass pec trometry) method. Bioinformatics annotation and analysis of the obtained proteins showed that the VDR (vitamin D receptor) and PIM1 (Ser/Thr-protein kinase-1) were significantly enriched in the vitamin D receptor signalling pathway (Rich factor > 0.6), and thirty high affinity proteins mainly involved in pathways in Cancer, MAPK (mitogenactivated protein kinase) signalling pathway, TNF (tumour necrosis factor) signalling pathway, Osteoclast differentiation. Among them, four high score affinity target proteins, CYP1B1 (cytochrome P4501B1), VDR, PIM1 and GAA were screened by reverse molecular docking. Finally, the two target proteins, VDR and PIM1, which provided important theoretical support for tricetin in anti-liver cancer research were fully discussed. *Correspondence to: Keping Chen, Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu, China, E-mail: kpchen@ujs.edu.cn","PeriodicalId":112494,"journal":{"name":"Frontiers in Drug, Chemistry and Clinical Research","volume":"79 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122456526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书